A Rare COVID-19 Presentation; Relapse of Nephrotic Syndrome in a Pediatric Patient

[LANGUAGE= "English"] Background: In early 2020, severe acute respiratory syndrome-corona virus 2 (SARS-CoV-2) pandemics caused previously unheard of health, social, and economic problems worldwide. The disease can affect different organs such as the lungs, heart, pancreas, kidney, and unu...

Full description

Saved in:
Bibliographic Details
Published in:Journal of Clinical Practice & Research 2023-01, Vol.45 (1), p.104
Main Authors: Çelegen, Kübra, Çeleğen, Mehmet, Bükülmez, Ayşegül
Format: Article
Language:English
Subjects:
Age groups
Case reports
COVID-19
Drug dosages
Edema
Kidney diseases
Pandemics
Pediatrics
Remission (Medicine)
Severe acute respiratory syndrome coronavirus 2
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:[LANGUAGE= "English"] Background: In early 2020, severe acute respiratory syndrome-corona virus 2 (SARS-CoV-2) pandemics caused previously unheard of health, social, and economic problems worldwide. The disease can affect different organs such as the lungs, heart, pancreas, kidney, and unusual symptoms can be seen. Information on the clinical impact of SARS-CoV-2 infection on renal function among pediatric age groups is scarce.Case Report: In this report, we presented a 13-year-old boy who was admitted to our hospital with the relapse of nephrotic syndrome caused by COVID-19. The patient had mild upper respiratory tract symptoms, eyelid edema and progressive swelling of the lower extremities. Clinical remission was achieved with oral prednisolone therapy without the use of any antiviral drugs.Conclusion: Patients with nephrotic syndrome presenting with relapse should be evaluated for potential COVID-19 infec-tion during the pandemic. The use of routine doses of prednisolone appears to be safe in mild disease.
ISSN:2980-2156
DOI:10.14744/etd.2022.47701